Crowley Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Crowley Wealth Management's BMY Position: Q4 2025 in Review
Crowley Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 776 shares — an estimated $35K sold.
Crowley Wealth Management first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $47.3K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Crowley Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Crowley Wealth Management sold 776 Bristol-Myers Squibb shares in Q4 2025, an estimated $35K.
- Crowley Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
- Crowley Wealth Management's Bristol-Myers Squibb position peaked at $47.3K in Q1 2025.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Crowley Wealth Management's 13F filing for Q4 2025.